Work

On specialty pharmaceuticals: reflections of a second-year medical student.

Year: 2006

Type: article

Abstract: High cost and lack of evidence-based data for biologics used to treat rare diseases raise coverage questions for payers. Are clinical practice guidelines the answer?

Source: Europe PMC (PubMed Central)

Author: Ross E Breitbart

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

Open Access status: green

OpenAlex ID: W2256092410

FWCI:

Cites: 14

Cited by:

Related to: 10